Okay, let's tackle this question. The patient is a 35-year-old woman with six months of excessive bleeding that hasn't responded to non-hormonal drugs. The ultrasound and clinical exam are normal. The next step is to find out what's causing this.

First, the core concept here is about managing abnormal uterine bleeding. The key is to determine the cause when initial steps fail. Since non-hormonal drugs like NSAIDs or tranexamic acid didn't work, and imaging is normal, we need to consider other diagnostic approaches.

The correct answer is probably to do a hysteroscopy or endometrial biopsy. Wait, but the options aren't given here. Hmm. If the USG is normal, maybe there's a need for further investigation. Endometrial sampling is crucial to rule out hyperplasia or malignancy. So, the next step would be to perform an endometrial biopsy. That makes sense because if the bleeding is prolonged and uncontrolled, endometrial cancer is a risk, especially in perimenopausal women. So, endometrial biopsy or hysteroscopy with biopsy would be the next step.

Now, the wrong options might include things like hormonal therapy, which is a treatment option but not the next step for diagnosis. Or maybe a D&C, which is more invasive. Alternatively, maybe a CT scan or MRI, but those aren't first-line for this. Also, if the USG is normal, perhaps a repeat USG isn't necessary. So the options might be a mix of treatments and other tests.

The clinical pearl here is that in women with persistent AUB not controlled by initial therapy, endometrial sampling is essential to exclude malignancy or hyperplasia. Remembering that hysteroscopy allows direct visualization and targeted biopsy is key.

**Core Concept**
The management of abnormal uterine bleeding (AUB) in reproductive-age women involves a stepwise approach. When non-hormonal therapies fail and imaging is unremarkable, endometrial sampling is critical to exclude premalignant or malignant pathology. The key principle is to prioritize diagnostic accuracy to guide targeted treatment.

**Why the Correct Answer is Right**
Endometrial biopsy or hysteroscopy with biopsy is the next step to evaluate for endometrial hyperplasia, polyps, or malignancy. Prolonged anovulation (common in PCOS) or other causes of unopposed estrogen can lead to endometrial changes. Direct visualization via hysteroscopy allows targeted sampling, improving diagnostic yield compared to blind biopsy. This is especially critical in perimenopausal women with prolonged bleeding.

**Why Each Wrong Option is Incorrect**
**Option A:** Hormonal therapy (e.g., progestins) is treatment, not diagnostic. Requires prior confirmation of ovulatory cycles.
**Option B:** Repeat ultrasound is redundant if initial imaging was normal.
**Option C:** MRI is not first-line for AUB; reserved for complex cases with suspicion of uterine fibroids/adenomyosis.
**Option D:** Dilation and curettage (D&C) is invasive and outdated; hysteroscopy is preferred for better visualization and lower complication rates.

**Clinical Pearl / High-Yield Fact**
Never skip endometrial sampling in women with AUB lasting >6 months, especially in perimenopausal patients

✓ Correct Answer: B. Endometrial sampling